Beam Therapeutics

Guide Therapeutics, Inc. is a biotechnology company focused on the delivery of genetic therapies through its proprietary nanoparticle screening platform. Founded in 2018 and based in Tucker, Georgia, the company utilizes patented technologies to test a wide array of chemically distinct nanoparticles in vivo. This approach enables the identification of simple, scalable, and clinically relevant nanoparticles capable of targeting new cell types with efficiency and safety. Guide Therapeutics develops innovative drug delivery vehicles that can transport DNA or RNA to cells that are typically unreachable by conventional methods. By assigning a unique barcode to each nanoparticle and incorporating a reporter molecule, the company tracks the delivery and efficacy of its therapeutics, providing a novel solution for treating diseases at their genetic roots.